These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


87 related items for PubMed ID: 1589629

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Bacterial resistance in the new millennium. Its impact on antibiotic selection for respiratory tract infections.
    Appelbaum PC.
    Postgrad Med; 2000 Dec; 108(7 Suppl Contemporaty):5-16. PubMed ID: 19667544
    [Abstract] [Full Text] [Related]

  • 4. [Antibiotic strategy in lower respiratory infections in children].
    Gendrel D.
    Rev Prat; 1996 Nov 01; 46(17):2099-103. PubMed ID: 8978166
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [beta-lactam-antibiotics in the treatment of community-acquired respiratory tract infections with penicillin-resistant pneumococci].
    Brauers J, Ewig S, Kresken M.
    Pneumologie; 2002 Oct 01; 56(10):605-9. PubMed ID: 12375222
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia.
    Feldman C.
    J Lab Clin Med; 2004 May 01; 143(5):269-83. PubMed ID: 15122171
    [Abstract] [Full Text] [Related]

  • 12. Initial antibiotic selection and patient outcomes: observations from the National Pneumonia Project.
    Bratzler DW, Ma A, Nsa W.
    Clin Infect Dis; 2008 Dec 01; 47 Suppl 3():S193-201. PubMed ID: 18986289
    [Abstract] [Full Text] [Related]

  • 13. Population antibiotic susceptibility for Streptococcus pneumoniae and treatment outcomes in common respiratory tract infections.
    Furuno JP, Metlay JP, Harnett JP, Wilson J, Langenberg P, McGregor JC, Zhu J, Perencevich EN.
    Pharmacoepidemiol Drug Saf; 2006 Jan 01; 15(1):1-9. PubMed ID: 16136615
    [Abstract] [Full Text] [Related]

  • 14. Acute bacterial rhinosinusitis in pediatric medicine: current issues in diagnosis and management.
    Anon JB.
    Paediatr Drugs; 2003 Jan 01; 5 Suppl 1():25-33. PubMed ID: 14632103
    [Abstract] [Full Text] [Related]

  • 15. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
    Deal EN, Micek ST, Reichley RM, Ritchie DJ.
    Clin Ther; 2009 Feb 01; 31(2):299-310. PubMed ID: 19302902
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?
    Amsden GW.
    J Antimicrob Chemother; 2005 Jan 01; 55(1):10-21. PubMed ID: 15590715
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Bacteriological aspects of infections of the upper respiratory tract.
    Kallings LO.
    Scand J Infect Dis Suppl; 1983 Jan 01; 39():9-13. PubMed ID: 6580737
    [Abstract] [Full Text] [Related]

  • 20. [Comparison of empirical treatment with antibiotics in community acquired lung diseases].
    Dolmann AL, Forti IN, Bernabó JG.
    Medicina (B Aires); 1989 Jan 01; 49(1):14-20. PubMed ID: 2698435
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.